Together, Thomas L. Mindt and his cooperation-partners Wolfgang Kandioller (University of Vienna) and Berthold Nock (Demokritos, Athens) received a grant by the Austrian Science Fund for the new project on “Metabolically Stabilized Peptidomimetics for Improved Tumour Targeting”. Go and read more about the project..
On February the 1st, 2018 our first Scientific Advisory Board Meeting took place. Five internationally renowned experts visited our institute with the purpose to evaluate and review our research.The meeting started with a welcome note by Vice Rector Dipl.-Ing. Dr Michaela Fritz. She emphasised the importance of personalised and translational medicine as well as the […]
24th – 27th January 2018, the LBI:AD was part of the 33rd International Austrian Winter Symposium that was organized by the Austrian Society of Nuclear Medicine & Molecular Imaging together with the 13th ALPE ADRIA Nuclear Medicine Symposium. Traditionally, the scientific event was supported by the wonderful atmosphere of Zell am See, Austria.An intriguing start […]
The European Association of Nuclear Medicine (EANM) meets annualy in an European city to discuss the newest trends and findings in the field of nuclear medicine. The EANM congress provides great possibilities to network and socialise while learning about the scientific progress in different countries and research institutes.This year’s EANM took place during the 21st […]
For the third time since 2013, the national meeting of OGNMB was held in the modern Ferry Porsche Congress Centre (FPCC) in Zell am See. Due to the great success in the recent years, the focus of the congress was on interdisciplinary sessions jointly organized by nuclear physicians, physicists, radiopharmacists and radiological technologists.During two and […]
On the 21th December 2016, the LBI Applied Diagnostics held its first Board of Partners Meeting in the famous Viennese Adolf Looshaus with a subsequent historical tour. Happily, all partners were represented physically or via dial-in possibility. Therefore, important decisions about the future of the institute could be made. We are happy to announce that […]
Die Vorstellung des Institutes erfolgte im Rahmen des Weinherbstes der Ludwig Boltzmann Gesellschaft am 20. Oktober 2015 im Beisein des Präsidenten der Ludwig Boltzmann Gesellschaft, DI Josef Pröll.Neues Ludwig Boltzmann Institut für Angewandte Diagnostik am AKH: „Liquid Biopsies“ und „Imaging Biomarker“ werden kombiniert, um eine neue zielgerichtete Molekulare Bildgebung zu ermöglichen Der wissenschaftliche Fokus des […]